Literature DB >> 24936736

An uncommon case of Marine-Lenhart syndrome.

Giuseppe Giuffrida1, Salvatore Giovinazzo1, Rosaria Certo1, Teresa Manuela Vicchio1, Sergio Baldari2, Alfredo Campennì2, Rosaria Maddalena Ruggeri1.   

Abstract

The term Marine-Lenhart syndrome describes the association between Graves' disease and autonomously functioning thyroid nodules (AFTN), such as toxic adenoma or toxic multinodular goiter. The two diseases may coexist or may be present at different moments in the same patient. In the literature, there are many reports on the development of Graves' disease after radioiodine treatment for AFTN, but very little information may be found on the occurrence of AFTN after radioiodine therapy for Graves' disease. We describe here the case of a female patient with Graves' disease who was successfully treated with radioiodine for Graves' disease, returning to normal thyroid function. Three years later, biochemical analysis and ultrasound examination identified a thyroid nodule that progressively increased in size. The 99mTc-pertechnetate scintigraphy showed avid uptake in the right lobule, which corresponded to a nodular lesion consistent with AFTN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24936736     DOI: 10.1590/0004-2730000003173

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  3 in total

1.  Marine-Lenhart Syndrome: Case Report, Diagnosis, and Management.

Authors:  Danielle Neuman; Russ Kuker; Francesco Vendrame
Journal:  Case Rep Endocrinol       Date:  2018-10-24

2.  Recurrent Goiter Presented with Marine-Lenhart Syndrome 27 Years After Initial Surgery.

Authors:  Emin Gurleyik
Journal:  Cureus       Date:  2019-09-26

3.  Type 2 Marine-Lenhart Syndrome: An Uncommon Cause of Thyrotoxicosis.

Authors:  Carlos Alfonso Builes Barrera; Pablo Alberto Castaño; Paula Herrera Revollo; Marcel Eduardo Pérez Paternina; Luis Antonio Rodriguez Arrieta
Journal:  Cureus       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.